NCT01192425

Brief Summary

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,580

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

September 1, 2010

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

Same day

First QC Date

August 30, 2010

Last Update Submit

June 22, 2026

Conditions

Hemoglobinuria

Keywords

PNH clone cellsAplastic AnemiaAAMyelodysplastic SyndromesMDSbone marrow failure syndromesFLAERParoxysmal Nocturnal Hemoglobinuria

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients at least 10 years of age with aplastic anemia, myelodyplastic syndromes or other bone marrow failure syndromes.

You may qualify if:

  • At least 10 years of age.
  • Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes

You may not qualify if:

  • Has any condition that might interfere with the patient's participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HemoglobinuriaAnemia, AplasticMyelodysplastic SyndromesBone Marrow Failure DisordersHemoglobinuria, Paroxysmal

Condition Hierarchy (Ancestors)

ProteinuriaUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsAnemiaHematologic DiseasesHemic and Lymphatic DiseasesBone Marrow DiseasesAnemia, Hemolytic

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2010

First Posted

September 1, 2010

Study Start

September 1, 2010

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

June 24, 2026

Record last verified: 2026-06